Luc Girard

24.6k citations

168 papers · 12.2k indexed · 1 hit paper · h-index 60

Molecular Biology top 0.5%
Oncology top 0.5%
Cancer Research top 0.2%
Pulmonary and Respiratory Medicine top 0.5%
Genetics top 1%

Co-authors: John D. Minna Adi F. Gazdar Ignacio I. Wistuba Yang Xie Michael Peyton Carmen Behrens Wan L. Lam Jonathan R. Pollack
Topics: Lung Cancer Treatments and Mutations (29 papers)RNA modifications and cancer (27 papers)Lung Cancer Research Studies (21 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Japan China

In The Last Decade

Luc Girard

165 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

2009 611 citations Luc Girard, Adi F. Gazdar et al. profile →

Peers

Countries citing papers authored by Luc Girard

Since Specialization

Citations

This map shows the geographic impact of Luc Girard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Girard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Girard more than expected).

Fields of papers citing papers by Luc Girard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Girard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Girard. The network helps show where Luc Girard may publish in the future.

Co-authorship network of co-authors of Luc Girard

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Girard. A scholar is included among the top collaborators of Luc Girard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Girard. Luc Girard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis 2018 ·Cancer Research ·Xiang Yan,Xiaoshan Zhang,Li Wang,Ran Zhang,Xingxiang Pu,Shuhong Wu,Lei Li,Pan Tong,Jing Wang,Qing H. Meng,V. Behrana Jensen,Luc Girard,John D. Minna,Jack A. Roth,Stephen G. Swisher,John V. Heymach,Bingliang Fang	62
2	Kub5-Hera RPRD1B Deficiency Promotes “BRCAness” and Vulnerability to PARP Inhibition in BRCA-proficient Breast Cancers 2018 ·Clinical Cancer Research ·Edward A. Motea,Farjana Fattah,Ling Xiao,Luc Girard,Amy Rommel,Julio C. Morales,Praveen Patidar,Yunyun Zhou,Andrew C.G. Porter,Yang Xie,John D. Minna,David A. Boothman	12
3	GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma 2017 ·Cancer Research ·Sahba Kasiri,(unknown),Baozhi Chen,(unknown),Paul Yenerall,Brenda C. Timmons,Luc Girard,Hui Tian,Carmen Behrens,Ignacio I. Wistuba,Adi F. Gazdar,James Kim	26
4	PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis 2016 ·Cancer Research ·Xiaorong Zhou,Barrett L. Updegraff,Yabin Guo,Michael Peyton,Luc Girard,Jill E. Larsen,Xian‐Jin Xie,(unknown),Tae Hyun Hwang,Yang Xie,Jaime Rodriguez‐Canales,Pamela Villalobos,Carmen Behrens,Ignacio I. Wistuba,John D. Minna,Kathryn A. O’Donnell	56
5	Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5 2015 ·Molecular Cancer Research ·Hui Tian,Jui-Yun Lu,(unknown),Kenneth E. Huffman,(unknown),Jill E. Larsen,Luc Girard,Hui Liu,Jaime Rodriguez‐Canales,Eugene P. Frenkel,Ignacio I. Wistuba,John D. Minna,Sandra L. Hofmann	37
6	Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer 2014 ·Clinical Cancer Research ·Oliver Delgado,Kimberly Batten,James A. Richardson,(unknown),Adi F. Gazdar,(unknown),Luc Girard,Carmen Behrens,Milind Suraokar,(unknown),Woodring E. Wright,Michael D. Story,Ignacio I. Wistuba,John D. Minna,Jerry W. Shay	23
7	Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis 2014 ·Molecular Cancer Research ·Katja Schuster,Niranjan Venkateswaran,Andrea Rabellino,Luc Girard,Samuel Peña‐Llopis,Pier Paolo Scaglioni	31
8	A Search for Novel Cancer/Testis Antigens in Lung Cancer Identifies VCX/Y Genes, Expanding the Repertoire of Potential Immunotherapeutic Targets 2014 ·Cancer Research ·Ayumu Taguchi,Allen D. Taylor,Jaime Rodriguez‐Canales,Müge Çeliktaş,Hui Liu,Xiaotu Ma,Qing Zhang,Chee‐Hong Wong,Alice Chin,Luc Girard,Carmen Behrens,Wan L. Lam,Stephen Lam,John D. Minna,Ignacio I. Wistuba,Adi F. Gazdar,Samir Hanash	36
9	VEGF/VEGFR-2 Upregulates EZH2 Expression in Lung Adenocarcinoma Cells and EZH2 Depletion Enhances the Response to Platinum-Based and VEGFR-2–Targeted Therapy 2014 ·Clinical Cancer Research ·Erick Riquelme,Milind Suraokar,Carmen Behrens,Heather Lin,Luc Girard,Monique B. Nilsson,George R. Simon,Jing Wang,Kevin R. Coombes,J. Jack Lee,Waun Ki Hong,John V. Heymach,John D. Minna,Ignacio I. Wistuba	59
10	Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non–Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway 2014 ·Clinical Cancer Research ·(unknown),James P. Sullivan,Luc Girard,Alexander Augustyn,Paul Yenerall,Jaime Rodriguez‐Canales,Hui Liu,Carmen Behrens,Jerry W. Shay,Ignacio I. Wistuba,John D. Minna	135
11	The SUMO E3-ligase PIAS1 Regulates the Tumor Suppressor PML and Its Oncogenic Counterpart PML-RARA 2012 ·Cancer Research ·Andrea Rabellino,Brandon Carter,Georgia Konstantinidou,Shwu-Yuan Wu,Alessandro Rimessi,Lauren A. Byers,John V. Heymach,Luc Girard,Cheng-Ming Chiang,Julie Teruya‐Feldstein,Pier Paolo Scaglioni	94
12	Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion 2012 ·Molecular Cancer Therapeutics ·Pierre Saintigny,Shaohua Peng,Li Zhang,Banibrata Sen,Ignacio I. Wistuba,Scott M. Lippman,Luc Girard,John D. Minna,John V. Heymach,Faye M. Johnson	48
13	Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients 2011 ·Clinical Cancer Research ·Yang Xie,Guanghua Xiao,Kevin R. Coombes,Carmen Behrens,Luisa M. Solis,Gabriela Raso,Luc Girard,Heidi S. Erickson,Jack A. Roth,John V. Heymach,César A. Moran,K. D. Danenberg,John D. Minna,Ignacio I. Wistuba	130
14	Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy 2011 ·Molecular Cancer Therapeutics ·Noriaki Sunaga,David S. Shames,Luc Girard,Michael Peyton,Jill E. Larsen,Hisao Imai,Junichi Soh,Mitsuo Sato,Noriko Yanagitani,Kyoichi Kaira,Yang Xie,Adi F. Gazdar,Masatomo Mori,John D. Minna	135
15	Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy 2011 ·Cancer Research ·Fei Yang,Ximing Tang,Erick Riquelme,Carmen Behrens,Monique B. Nilsson,Uma Giri,Marileila Varella‐Garcia,Lauren A. Byers,Heather Lin,Jing Wang,Maria Gabriela Raso,Luc Girard,Kevin R. Coombes,J. Jack Lee,Roy S. Herbst,John D. Minna,John V. Heymach,Ignacio I. Wistuba	51
16	STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17 2011 ·Cancer Research ·Bingbing Dai,Jieru Meng,Michael Peyton,Luc Girard,William G. Bornmann,Lin Ji,John D. Minna,Bingliang Fang,Jack A. Roth	80
17	Steroid Receptor Coactivator-3 Expression in Lung Cancer and Its Role in the Regulation of Cancer Cell Survival and Proliferation 2010 ·Cancer Research ·Di Cai,David S. Shames,Maria Gabriela Raso,Yang Xie,Young Ho Kim,Jonathan R. Pollack,Luc Girard,James P. Sullivan,Boning Gao,Michael Peyton,Meera Nanjundan,Lauren A. Byers,John V. Heymach,Gordon B. Mills,Adi F. Gazdar,Ignacio I. Wistuba,Thomas Kodadek,John D. Minna	48
18	Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene 2008 ·Cancer Research ·Narayan Shivapurkar,Victor Stastny,Naoki Okumura,Luc Girard,Yang Xie,Clemens Prinsen,Erik Thunnissen,Ignacio I. Wistuba,Bogdan Czerniak,Eugene P. Frenkel,Jack A. Roth,Triantafillos Liloglou,George Xinarianos,John K. Field,John D. Minna,Adi F. Gazdar	91
19	Non–Small Cell Lung Cancers with Kinase Domain Mutations in the Epidermal Growth Factor Receptor Are Sensitive to Ionizing Radiation 2006 ·Cancer Research ·Amit Kumar Das,Mitsuo Sato,Michael D. Story,Michael Peyton,Robert J. Graves,Stella Redpath,Luc Girard,Adi F. Gazdar,Jerry W. Shay,John D. Minna,Chaitanya S. Nirodi	178
20	Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis 2005 ·Cancer Research ·Xiaojun Zhao,Barbara A. Weir,Thomas LaFramboise,Ming Gang Lin,Rameen Beroukhim,Levi A. Garraway,Javad Beheshti,Jeffrey C. Lee,Katsuhiko Naoki,William G. Richards,David J. Sugarbaker,Fei Chen,Mark A. Rubin,Pasi A. Jänne,Luc Girard,John D. Minna,David C. Christiani,Cheng Li,William R. Sellers,Matthew Meyerson	242

About Luc Girard

Luc Girard is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 168 papers that have together received 12.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (29 papers), RNA modifications and cancer (27 papers) and Lung Cancer Research Studies (21 papers). The work is most often cited by research in Cancer Research (3.0k citations), Oncology (4.5k citations) and Molecular Biology (8.1k citations). Luc Girard has collaborated with scholars based in United States, Japan and China. Frequent co-authors include John D. Minna, Adi F. Gazdar, Ignacio I. Wistuba, Yang Xie, Michael Peyton, Carmen Behrens, Wan L. Lam, Jonathan R. Pollack, Mitsuo Sato and Pei Wang. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact